151 related articles for article (PubMed ID: 38509597)
1. Brivaracetam and topiramate serum levels during pregnancy and delivery: a case report and a review of literature.
Hahn W; Möller L; Menzler K; Poeplau T; Wagner U; Knake S
Neurol Res Pract; 2024 Mar; 6(1):17. PubMed ID: 38509597
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, safety, and tolerability of brivaracetam with concomitant lamotrigine or concomitant topiramate in pooled Phase III randomized, double-blind trials: A post-hoc analysis.
Benbadis S; Klein P; Schiemann J; Diaz A; Elmoufti S; Whitesides J
Epilepsy Behav; 2018 Mar; 80():129-134. PubMed ID: 29414542
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic data on brivaracetam, lacosamide and perampanel during pregnancy and lactation.
Landmark CJ; Rektorli L; Burns ML; Revdal E; Johannessen SI; Brodtkorb E
Epileptic Disord; 2021 Apr; 23(2):426-431. PubMed ID: 33935028
[TBL] [Abstract][Full Text] [Related]
4. Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review.
Steinhoff BJ; Klein P; Klitgaard H; Laloyaux C; Moseley BD; Ricchetti-Masterson K; Rosenow F; Sirven JI; Smith B; Stern JM; Toledo M; Zipfel PA; Villanueva V
Epilepsy Behav; 2021 May; 118():107939. PubMed ID: 33839453
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive brivaracetam - A prospective audit of outcomes from an epilepsy clinic.
Stephen L; Brodie MJ
Epilepsy Behav; 2021 Mar; 116():107746. PubMed ID: 33517200
[TBL] [Abstract][Full Text] [Related]
6. Retention of brivaracetam in adults with drug-resistant epilepsy at a single tertiary care center.
Green SF; Hare N; Kassam M; Rugg-Gunn F; Koepp MJ; Sander JW; Rajakulendran S
Epilepsy Behav; 2022 Oct; 135():108868. PubMed ID: 35985166
[TBL] [Abstract][Full Text] [Related]
7. Potential role of brivaracetam in pediatric epilepsy.
Verrotti A; Grasso EA; Cacciatore M; Matricardi S; Striano P
Acta Neurol Scand; 2021 Jan; 143(1):19-26. PubMed ID: 32966640
[TBL] [Abstract][Full Text] [Related]
8. Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.
Ryvlin P; Dimova S; Elmoufti S; Floricel F; Laloyaux C; Nondonfaz X; Biton V
Epilepsia; 2022 Aug; 63(8):2024-2036. PubMed ID: 35582748
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Brivaracetam in Persons With Epilepsy in a Real-World Setting: A Prospective, Non-Interventional Study.
Siddiqui F; Soomro BA; Badshah M; Rehman EU; Numan A; Ikram A; Khan MWA; Ali S; Hashim H; Salam JU; Akram A; Irfan Hashmat M; Iqbal S; Zeeshan Javed M; Iqbal SZ; Maqsood A; Khan A; Maheshwary N; Khan MA
Cureus; 2023 Dec; 15(12):e50313. PubMed ID: 38205459
[TBL] [Abstract][Full Text] [Related]
10. Brivaracetam as adjunctive therapy for the treatment of partial-onset seizures in patients with epilepsy: the current evidence base.
Brandt C; May TW; Bien CG
Ther Adv Neurol Disord; 2016 Nov; 9(6):474-482. PubMed ID: 27800023
[TBL] [Abstract][Full Text] [Related]
11. An update on brivaracetam for the treatment of pediatric partial epilepsy.
Tulli E; Di Cara G; Iapadre G; Striano P; Verrotti A
Expert Opin Pharmacother; 2021 Aug; 22(11):1387-1395. PubMed ID: 33896317
[No Abstract] [Full Text] [Related]
12. Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST).
Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Irelli EC; Chiesa V; Dainese F; De Maria G; Didato G; Gennaro GD; Falcicchio G; Fanella M; Ferlazzo E; Gangitano M; La Neve A; Mecarelli O; Montalenti E; Morano A; Piazza F; Pizzanelli C; Pulitano P; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
Seizure; 2022 Apr; 97():37-42. PubMed ID: 35320736
[TBL] [Abstract][Full Text] [Related]
13. Increasing use of newer antiseizure medication during pregnancy: An observational study with special focus on lacosamide.
Hoeltzenbein M; Slimi S; Fietz AK; Stegherr R; Onken M; Beyersmann J; Dathe K; Schaefer C
Seizure; 2023 Apr; 107():107-113. PubMed ID: 37003184
[TBL] [Abstract][Full Text] [Related]
14. Value of drug level concentrations of brivaracetam, lacosamide, and perampanel in care of people with epilepsy.
Hentschel M; Stoffel-Wagner B; Surges R; von Wrede R; Dolscheid-Pommerich RC
Epilepsia; 2024 Mar; 65(3):620-629. PubMed ID: 38158709
[TBL] [Abstract][Full Text] [Related]
15. Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.
Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Cerulli Irelli E; Chiesa V; Dainese F; De Maria G; Didato G; Di Gennaro G; Falcicchio G; Fanella M; Ferlazzo E; Gangitano M; La Neve A; Mecarelli O; Montalenti E; Morano A; Piazza F; Pizzanelli C; Pulitano P; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
Neurol Ther; 2022 Dec; 11(4):1789-1804. PubMed ID: 36109431
[TBL] [Abstract][Full Text] [Related]
16. Rapid switching from levetiracetam to brivaracetam in pharmaco-resistant epilepsy in people with and without intellectual disabilities: a naturalistic case control study.
Watkins LV; Dunstall H; Musicha C; Lawthom C; John K; Bright C; Richings C; Harding K; Moon S; Pape SE; Winterhalder R; Allgar V; Thomas RH; McLean B; Laugharne R; Shankar R
J Neurol; 2023 Dec; 270(12):5889-5902. PubMed ID: 37610448
[TBL] [Abstract][Full Text] [Related]
17. Brivaracetam in the treatment of epilepsy: a review of clinical trial data.
Feyissa AM
Neuropsychiatr Dis Treat; 2019; 15():2587-2600. PubMed ID: 31571877
[TBL] [Abstract][Full Text] [Related]
18. Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
Strzelczyk A; Schubert-Bast S
CNS Drugs; 2022 Oct; 36(10):1079-1111. PubMed ID: 36194365
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, safety, and tolerability of intravenous brivaracetam in pediatric patients with epilepsy: An open-label trial.
Farkas MK; Kang H; Fogarasi A; Bozorg A; James GD; Krauwinkel W; Morita D; Will E; Elshoff JP
Epilepsia; 2022 Apr; 63(4):855-864. PubMed ID: 35196395
[TBL] [Abstract][Full Text] [Related]
20. A review of the pharmacology and clinical efficacy of brivaracetam.
Klein P; Diaz A; Gasalla T; Whitesides J
Clin Pharmacol; 2018; 10():1-22. PubMed ID: 29403319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
